<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Humoral response in <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients appears early in <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">cancer progression</z:e> and can be used for diagnosis, including early detection </plain></SENT>
<SENT sid="1" pm="."><plain>By using human recombinant protein and T7 phage microarrays displaying <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>)-specific <z:chebi fb="7" ids="16670">peptides</z:chebi>, we previously selected 6 phages and 6 human recombinant proteins as <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated antigens (<z:chebi fb="2" ids="32497">TAAs</z:chebi>) with high diagnostic value </plain></SENT>
<SENT sid="2" pm="."><plain>After completing validation in biological samples, <z:chebi fb="2" ids="32497">TAAs</z:chebi> were classified according to their correlation, redundancy in reactivity patterns and multiplex diagnostic capabilities </plain></SENT>
<SENT sid="3" pm="."><plain>For predictor model optimization, <z:chebi fb="2" ids="32497">TAAs</z:chebi> were reanalyzed with a new set of samples </plain></SENT>
<SENT sid="4" pm="."><plain>A combination of three phages displaying <z:chebi fb="7" ids="16670">peptides</z:chebi> homologous to GRN, NHSL1 and SREBF2 and four proteins PIM1, MAPKAPK3, FGFR4 and ACVR2B, achieved an area under the curve (AUC) of 94%, with a sensitivity of 89.1% and specificity of 90.0%, to correctly predict the presence of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>For early <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> stages, the AUC was 90%, with a sensitivity of 88.2% and specificity of 82.6% </plain></SENT>
<SENT sid="6" pm="."><plain>In summary, we have defined an optimized predictor panel, combining <z:chebi fb="2" ids="32497">TAAs</z:chebi> from different sources, with highly improved accuracy and diagnostic value for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>This article is part of a Special Issue entitled: Translational Proteomics </plain></SENT>
</text></document>